yihan li - Data and Statistical Science, AbbVie Inc

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 55 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Upadacitinib in Active Non‐radiographic Axial Spondyloarthritis: 1‐year Data from a Double‐Blind, Randomized, Placebo‐Controlled, Phase 3 Trial

Filip Van den Bosch,Atul Deodhar,Denis Poddubnyy,Walter P. Maksymowych,Desiree van der Heijde,Tae-Hwan Kim,Mitsumasa Kishimoto,Xenofon Baraliakos,Yihan Li,Kristin D'Silva,Peter Wung,In-Ho Song

ACR OPEN RHEUMATOLOGYno. 8 (2024): 470-480

引用1浏览0WOS引用

Long-term Safety and Efficacy of Upadacitinib Versus Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from the Phase 3, Randomised SELECT-COMPARE Study

Roy Fleischmann,Jerzy Swierkot,Sara K. Penn,Patrick Durez,Louis Bessette,Xianwei Bu,Nasser Khan,Yihan Li,Charles G. Peterfy,Yoshiya Tanaka,Eduardo Mysler

RMD Openno. 2 (2024): e004007-e004007

引用2浏览0WOS引用

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: 5-year data from the select-compare study

R. M. Fleischmann,J. Swierkot, S. Penn,P. Durez,L. Bessette,X. Bu,N. Khan,Y. Li,C. Peterfy, Y. Tanaka,E. Mysler

ANNALS OF THE RHEUMATIC DISEASES（2023）

引用0浏览0引用

Upadacitinib Monotherapy Versus Methotrexate Monotherapy in Patients with Rheumatoid Arthritis: Efficacy and Safety Through 5 Years in the SELECT-EARLY Randomized Controlled Trial

Ronald van Vollenhoven,Vibeke Strand,Tsutomu Takeuchi,Nilmo Chávez, Pablo Mannucci Walter,Atul Singhal,Jerzy Swierkot,Nasser Khan,Xianwei Bu,Yihan Li,Sara K. Penn,Heidi S. Camp,Jacob Aelion

ARTHRITIS & RHEUMATOLOGY (2023): 890-894

引用0浏览0WOS引用

Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 3-Year Results from the Open-Label Extension of the Randomised Controlled Phase 3 SELECT-PsA 2 Study

Philip Mease,Arathi Setty,Kim Papp,Filip Van den Bosch,Shigeyoshi Tsuji,Mauro Keiserman,Kyle Carter,Yihan Li,Reva McCaskill,Erin McDearmon-Blondell,Peter Wung,William Tillett

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2023）

引用2浏览0WOS引用

Efficacy and Safety of Upadacitinib in Patients with Ankylosing Spondylitis Refractory to Biologic Therapy: 1-Year Results from the Open-Label Extension of a Phase III Study

Xenofon Baraliakos,Désirée van der Heijde,Joachim Sieper,Robert D. Inman,Hideto Kameda,Yihan Li,Xianwei Bu,Anna Shmagel,Peter Wung,In-Ho Song,Atul Deodhar

ARTHRITIS RESEARCH & THERAPY（2023）

引用8浏览0WOS引用

POS0849 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM THE SELECT-COMPARE STUDY

R.M. Fleischmann,J. Swierkot, S. Penn,P. Durez,L. Bessette,X. Bu,N. Khan,Y. LI,C. Peterfy, Y. Tanaka,E. Mysler

Annals of the Rheumatic Diseases (2023): 725-726

引用0浏览0引用

Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study

Alan Kivitz,Alvin F. Wells,Juan I. Vargas,Herbert S. B. Baraf,Maureen Rischmueller,Justin Klaff,Nasser Khan,Yihan Li,Kyle Carter,Alan Friedman,Patrick Durez

RHEUMATOLOGY AND THERAPY（2023）

引用0浏览0WOS引用

Inhibition of Structural Joint Damage Progression with Upadacitinib in Rheumatoid Arthritis: 1-Year Outcomes from the SELECT Phase 3 Program

Charles G. Peterfy,Vibeke Strand,Alan Friedman,Stephen Hall,Eduardo Mysler,Patrick Durez,Xenofon Baraliakos,Jeffrey Enejosa,Tim Shaw,Yihan Li,Su Chen,In-Ho Song

RHEUMATOLOGY（2022）

引用5浏览0WOS引用

Evaluation of Response to 13-Valent Conjugated Pneumococcal Vaccination in Patients with Rheumatoid Arthritis Receiving Upadacitinib: Results from a Phase 2 Open-Label Extension Study

Kevin Winthrop,Juan Ignacio Vargas,Edit Drescher,Conrado Garcia,Alan Friedman,Barbara Hendrickson,Yihan Li,Justin Klaff,Alan Kivitz

RMD Open（2022）

引用6浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn